Pilot study to determine the intraTUMORal OsImertinib concentration in patients with peritoneal metastasizeD colorectal cancer (TUMOROID study) - Trial 2022-003460-24
Access comprehensive clinical trial information for 2022-003460-24 through Pure Global AI's free database. This phase not specified trial is sponsored by Radboud University Medical Center and is currently Ongoing. The study focuses on Colorectal cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2022-003460-24
Ongoing
Trial Details
EU Clinical Trials Register • 2022-003460-24
Pilot study to determine the intraTUMORal OsImertinib concentration in patients with peritoneal metastasizeD colorectal cancer (TUMOROID study)
Study Focus
Sponsor & Location
Radboud University Medical Center
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
• Not fit to undergo surgery
ICD-10 Classifications
Malignant neoplasm of colon
Malignant neoplasm: Descending colon
Malignant neoplasm: Colon, unspecified
Malignant neoplasm: Ascending colon
Malignant neoplasm: Overlapping lesion of colon
Data Source
EU Clinical Trials Register
2022-003460-24
Non-Device Trial